Australia's largest stock trading and investment forum Australia's #1 stock forum

MSB

0.76%

$1.31 mesoblast limited

Thanks @Pharmagang, I appreciate your perspective

First 18888 Last

Share
Profile

Follow
Zenox

1,216 Posts.

1375

10/07/20

07:50

Post #: 45767204
Share

Originally posted by Pharmagang: ↑

@Zenox well cellular therapies are still a relatively new area - there's only ~17 approved in the US total, so it's all being done for the first time. If remestemcel-L and Multistem get approved for Covid-19 ARDS then they would both be able to request a label extension for non-Covid ARDS. In a traditional therapy, I would not see this hard to obtain for either company, but Athersys does have some phase I/II data in non-Covid ARDS. I don't know how much easier that will make the process but I don't think either company would find obtaining a label extension particularly hard, it's the same therapy for almost the same disease with a different route cause.

@6151 big pharma is always looking for acquisition opportunities, but if we get a positive result in Covid-19 ARDS then our market cap is going to be bigger than what they're used to. Whether it's a partnership, acquisition, or MSB run it themselves - that's more a decision for their executive for how they want to company to run I guess, all of those options will be great on the SP if we see efficacy.

Expand

Thanks @Pharmagang, I appreciate your perspective

MSB Price at posting: $3.73 Sentiment: Buy Disclosure: Held
1 Upvote

Reply

Top Stories

What each US election outcome would mean for Australian companies & investors

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

'We're looking': Nickel-rich Indonesia sounds graphite warning to Aus producers

Making money: How many microcaps should be in an investor's portfolio?

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

Aussie inflation seemingly hit a 3 year low. So why's the ASX200 red?

The Altcoin Landscape (Part 1): Key alternative cryptocurrencies to watch

Bitcoin hits fresh record as instos pile into BTC ETFs – and Trump helps, too

MIN

Movers and Shakers: Zip Co, MinRes, Kuniko, more – The week's top ASX gainers

Week 44 Wrap: Relatively boring week ahead of US election; HotCopper's most watched; Oz inflation at 3.5%

This thread is closed.

You may not reply to this discussion at this time.

First 18888 Last

Add MSB (ASX) to my watchlist

(20min delay)
Last $1.31		Change -0.010(0.76%)		Mkt cap ! $1.495B

Open	High	Low	Value	Volume
$1.31	$1.33	$1.28	$1.819M	1.396M

Buyers (Bids)

No.	Vol.	Price($)
2	29972	$1.31

Sellers (Offers)

Price($)	Vol.	No.
$1.31	2008	1

View Market Depth

No.	Vol.	Price($)
2	29972	1.305
4	15000	1.300
6	89978	1.295
10	88399	1.290
3	86112	1.285

Price($)	Vol.	No.
1.310	2008	1
1.315	12924	1
1.320	30099	5
1.325	32683	3
1.330	20707	3

Last trade - 16.10pm 01/11/2024 (20 minute delay)

MSB (ASX) Chart

Thanks @Pharmagang, I appreciate your perspective

What each US election outcome would mean for Australian companies & investors

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

'We're looking': Nickel-rich Indonesia sounds graphite warning to Aus producers

Making money: How many microcaps should be in an investor's portfolio?

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

Aussie inflation seemingly hit a 3 year low. So why's the ASX200 red?

The Altcoin Landscape (Part 1): Key alternative cryptocurrencies to watch

Bitcoin hits fresh record as instos pile into BTC ETFs – and Trump helps, too

Movers and Shakers: Zip Co, MinRes, Kuniko, more – The week's top ASX gainers

Week 44 Wrap: Relatively boring week ahead of US election; HotCopper's most watched; Oz inflation at 3.5%

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Thanks @Pharmagang, I appreciate your perspective

Top Stories

What each US election outcome would mean for Australian companies & investors

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

'We're looking': Nickel-rich Indonesia sounds graphite warning to Aus producers

Making money: How many microcaps should be in an investor's portfolio?

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

Aussie inflation seemingly hit a 3 year low. So why's the ASX200 red?

The Altcoin Landscape (Part 1): Key alternative cryptocurrencies to watch

Bitcoin hits fresh record as instos pile into BTC ETFs – and Trump helps, too

Movers and Shakers: Zip Co, MinRes, Kuniko, more – The week's top ASX gainers

Week 44 Wrap: Relatively boring week ahead of US election; HotCopper's most watched; Oz inflation at 3.5%

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News